13 research outputs found

    SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation

    No full text
    <div><p>The surfactant protein (SP-A) receptor SP-R210 has been shown to increase phagocytosis of SP-A-bound pathogens and to modulate cytokine secretion by immune cells. SP-A plays an important role in pulmonary immunity by enhancing opsonization and clearance of pathogens and by modulating macrophage inflammatory responses. Alternative splicing of the <i>Myo18A </i>gene results in two isoforms: SP-R210<sub>S</sub> and SP-R210<sub>L</sub>, with the latter predominantly expressed in alveolar macrophages. In this study we show that SP-A is required for optimal expression of SP-R210<sub>L</sub> on alveolar macrophages. Interestingly, pre-treatment with SP-A prepared by different methods either enhances or suppresses responsiveness to LPS, possibly due to differential co-isolation of SP-B or other proteins. We also report that dominant negative disruption of SP-R210<sub>L</sub> augments expression of receptors including SR-A, CD14, and CD36, and enhances macrophages’ inflammatory response to TLR stimulation. Finally, because SP-A is known to modulate CD14, we used a variety of techniques to investigate how SP-R210 mediates the effect of SP-A on CD14. These studies revealed a novel physical association between SP-R210<sub>S</sub>, CD14, and SR-A leading to an enhanced response to LPS, and found that SP-R210<sub>L</sub> and SP-R210<sub>S</sub> regulate internalization of CD14 via distinct macropinocytosis-like mechanisms. Together, our findings support a model in which SP-R210 isoforms differentially regulate trafficking, expression, and activation of innate immune receptors on macrophages.</p></div

    Increased responsiveness of SP-R210<sub>L</sub>(DN) cells to LPS.

    No full text
    <p>Control and SPR210<sub>L</sub>(DN) cells were plated in 12-well tissue culture dishes at a density of 150,000 cells/well and cultured 24 hrs in RPMI/10% FBS. Cells were then treated with 100 ng/mL LPS for 2, 4, 8, 16, and 24 hrs. A) Intracellular staining of TNFα was performed in brefeldin A blocked cells 2 hrs after treatment with LPS. Dotted histograms show untreated cells. Black, red, and blue histograms show intracellular TNFα staining of control, SP-R210<sub>L</sub>(DN)1, and SP-R210<sub>L</sub>(DN)2 cells. B) The levels of secreted TNFα were measured by ELISA in media at indicated time points after treatment with LPS. (n = 6; ***p<0.005).</p

    SP-A and SP-R210<sub>L</sub> modulate responsiveness of macrophages to LPS.

    No full text
    <p>Control and SP-R210<sub>L</sub>(DN) cells were pretreated with SP-A purified by either method 1 (SP-Am1) or method 2 (SP-Am2) as described in “Materials and Methods”. Cells were pretreated with indicated amounts of SP-Am1 (A) or SP-Am2 (B) for 24 hrs and then incubated with 100 ng/mL LPS. Levels of secreted TNFα were measured in media by ELISA at 4 hrs after addition of LPS. Data shown are means±SD, n = 3 representative of 3–6 independent experiments. Lines indicate significant differences between indicated groups at *p <0.0001; <sup>#</sup>p<0.04; <sup>$</sup>p<0.005</p

    Effect of SP-R210<sub>L</sub> disruption on CD14 and TLR-4 internalization and signaling.

    No full text
    <p>Macrophages cultured for 24 hrs on 12 well plates were simulated with 100 ng/mL LPS for indicated time points. The cells were then harvested at indicated time points using non-enzymatic cell displacement medium and stained with antibodies to CD14 (A and B) or TLR-4 (C). The effect of dynasore on internalization of CD14 (B) and of dynasore, EIPA, and NSC23766 on TNFα synthesis (D) was assessed by addition of inhibitors 30 min before addition of LPS. Harvested cells were analyzed by flow cytometry and mean fluorescence was expressed as % of control compared to non-stimulated control or SP-R210<sub>L</sub>(DN) cells (t = 0) (A-C) or as percent of control TNFα in SP-R210<sub>L</sub>(DN) cells compared to control cells (D). Data shown are means±SD, n = 2–4 independent experiments performed in triplicate. ***p<0.01, *p<0.04.</p

    Nuclear translocation of NFκB in control and SP-R210<sub>L</sub>(DN) cells.

    No full text
    <p>Macrophages were grown on glass coverslips for 24 hrs, and then stimulated with 100 ng/mL LPS. Stimulated cells were then processed for immunofluorescent staining with anti-p65 NFκB at indicated time points after LPS treatment. The nuclear localization of NFκB was visualized by confocal microscopy (A). The percentage of cells containing nuclear p65 was quantitated in 10 random microscopic fields at 100 x magnification (B). Data shown are means±SD, n = 2 independent experiments performed in duplicate. *p<0.05.</p

    Effect of neutralizing antibodies on the inflammatory response to LPS.

    No full text
    <p>Control and SP-R210<sub>L</sub>(DN) macrophages were pretreated for 60 min with 20 μg/mL of indicated individual or antibody combinations or respective isotype controls followed by stimulation with 100 ng/mL of LPS for 4 hrs. Cells were then harvested and processed for intracellular cytokine staining with TNFα antibodies. Stained cells were analyzed by flow cytometry. The mean fluorescence of positively stained cells was expressed as percent of isotype control treated cells. Data shown are means±SD and are pooled from 2–4 independent experiments performed in triplicate. *p<0.05.</p

    Proposed interaction of SP-R210 isoforms with CD14 and SR-A in macrophage activation.

    No full text
    <p>SP-R210<sub>L</sub> mediates macropinocytosis of LPS-CD14 through interaction with Rac1 resulting in endosomal LPS delivery to TLR-4 and downstream activation of NFκB. Subsequent degradation of LPS results in decrease NFκB signaling. SP-R210<sub>L</sub>-mediated macropinocytosis and signaling are sensitive to both EIPA and NSC23766. TLR-4 signaling from the cell-surface is sensitive to dynasore. Inhibition of SP-R210<sub>L</sub> expression results in formation of the SP-R210<sub>S</sub>-CD14-SR-A complex. Binding of LPS results in macropinocytosis-like internalization of the SP-R210<sub>S</sub>-CD14-SR-A complex and activation of a feed-forward inflammatory pathway that depends on activation of Rac1 by SR-A. The SP-R210<sub>S</sub>-CD14-SR-A pathway is sensitive to NSC23766 but not EIPA.</p

    Activation of TLR4 signaling in control and SP-R210<sub>L</sub>(DN) cells.

    No full text
    <p>Macrophages were stimulated with 100 ng/mL LPS and harvested at indicated time points. Non-stimulated (NS) and stimulated cells were harvested and processed for Western blot analysis. Blots were probed with IRAK-1 (A) or NFκB p65 (B) antibodies, stripped, and then reprobed with IκB or phosphorylated p65 antibodies, respectively. Blots were stripped and then re-probed with tubulin as loading control. Densitometry analysis compared the levels of phosphorylated p65 relative to tubulin (C). Blots in A and B are representative of 2–4 independent experiments. Data shown in C are means±SD, n = 2- independent experiments. *p<0.05.</p

    Depletion of SP-R210<sub>L</sub> differentially enhances expression of innate immune receptors in macrophages.

    No full text
    <p>Control and SP-R210<sub>L</sub>(DN) cells were analyzed by flow cytometry using indicated APC (A) or PE-conjugated antibodies (B, C) (n = 4–8). (D) mRNA levels of indicated receptors in SP-R210<sub>L</sub>(DN) cells relative to control cells were determined by qRT-PCR (n = 4 independent experiments performed in duplicate, **p<0.02, ***p<0.005).</p
    corecore